A 62-year-old man on ICU has severe ARDS. The team discusses the role of corticosteroids. The DEXA-ARDS trial examined dexamethasone in moderate-to-se...

Question

A 62-year-old man on ICU has severe ARDS. The team discusses the role of corticosteroids. The DEXA-ARDS trial examined dexamethasone in moderate-to-severe ARDS. What was the primary finding?

Accepted Answer

Dexamethasone 20 mg IV for 5 days then 10 mg for 5 days increased ventilator-free days and reduced 60-day mortality in moderate-to-severe ARDS

Answer

Dexamethasone increased mortality

Answer

Dexamethasone had no effect on any outcome

Answer

Dexamethasone worsened secondary infections significantly

Answer

Only methylprednisolone is effective in ARDS, not dexamethasone

uk-fficm MCQ (SBA): ARDS

A 62-year-old man on ICU has severe ARDS. The team discusses the role of corticosteroids. The DEXA-ARDS trial examined dexamethasone in moderate-to-severe ARDS. What was the primary finding?